Industrial Goods & Services
GlobalData is a business-intelligence and data company providing subscription-based information, analysis and workflow tools to corporate customers. Its products combine proprietary datasets, analyst research and increasingly AI-enabled technology.
Subscription data platforms, market intelligence, company and industry research, analytics, consulting and workflow tools serving sectors including healthcare, consumer, technology, financial services and professional markets.
A global business-to-business customer base, including large corporations, professional-services firms, financial institutions and government organisations.
Subscription growth, renewals, price increases, cross-selling, AI-enabled products, acquisitions, customer retention and successful integration of specialist data businesses.
Subscription cancellations, weak corporate spending, acquisition integration, competition from other data providers and generative AI, technology investment requirements and maintaining the quality and uniqueness of proprietary data.
9 July 2026: GlobalData reported first-half revenue growth of about 3% and EBITDA growth of 4-5%, announced a £30m tender offer and acquired Cambridge Healthcare Research. The shares entered the FTSE 250 in June after moving to the Main Market in March.
GlobalData pays dividends but income is secondary to growth and acquisitions. The FY2025 final dividend was 1.2p per share, taking the full-year total to 1.5p. The 2026 interim dividend had not yet been declared by 14 August.
The complete 350 Trade Book — 350 leading UK-listed companies, presented in one consistent working reference.